landiolol has been researched along with Endotoxin Shock in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Bion, J; Boota, N; Gates, S; Ghuman, B; Gordon, AC; Hill, M; Hossain, A; Innes, R; Lall, R; Lord, J; MacCallum, NS; McAuley, D; Mistry, D; Perkins, GD; Regan, SE; Singer, M; Skilton, E; Veenith, T; Welters, I; Whitehouse, T; Yeung, J; Young, D | 1 |
Bion, J; Boota, N; Gates, S; Gordon, AC; Lall, R; Lord, J; McAuley, DF; Mistry, D; Perkins, G; Regan, S; Singer, M; Skilton, E; Whitehouse, T; Young, D | 1 |
Arita, Y; Hasegawa, S; Segawa, T; Yamamoto, S | 1 |
Kawada, T; Li, M; Sugimachi, M; Uemura, K; Zheng, C | 1 |
Biancofiore, G; Bouvet, O; Cerny, V; Dostál, P; Girardis, M; Grohmann-Izay, B; Guarracino, F; Heinz, G; Joannidis, M; Kadlecova, P; Klade, C; Krejcy, K; Krumpl, G; Morelli, A; Pratesi, F; Radermacher, P; Rehberg, S; Siebers, C; Singer, M; Trimmel, H; Unger, M; Zörer, M | 1 |
2 trial(s) available for landiolol and Endotoxin Shock
Article | Year |
---|---|
Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial.
Topics: COVID-19; England; Humans; Morpholines; Randomized Controlled Trials as Topic; Shock, Septic; Treatment Outcome; Urea | 2021 |
Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Blood Pressure; Clinical Trials, Phase IV as Topic; Europe; Heart Rate; Humans; Intensive Care Units; Morpholines; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Shock, Septic; Time Factors; Treatment Outcome; Urea; Vasoconstrictor Agents | 2018 |
3 other study(ies) available for landiolol and Endotoxin Shock
Article | Year |
---|---|
Landiolol and Organ Failure in Patients With Septic Shock: The STRESS-L Randomized Clinical Trial.
Topics: Adrenergic beta-Antagonists; Adult; Female; Humans; Male; Middle Aged; Norepinephrine; Sepsis; Shock, Septic; State Medicine; Tachycardia | 2023 |
Landiolol is effective for the treatment of tachycardia-induced cardiogenic shock in patients during septic shock therapy.
Topics: Aged; Anti-Arrhythmia Agents; Diagnosis, Differential; Electrocardiography; Female; Humans; Morpholines; Shock, Cardiogenic; Shock, Septic; Tachycardia, Supraventricular; Urea | 2017 |
Low-Dose Landiolol Reduces Heart Rate and Cardiac Oxygen Consumption Without Compromising Initial Hemodynamic Resuscitation in a Canine Model of Endotoxin Shock.
Topics: Animals; Cardiac Output; Dogs; Female; Heart Rate; Hemodynamics; Male; Morpholines; Oxygen Consumption; Resuscitation; Shock, Septic; Urea | 2019 |